What Medicare Agents and Agency Leaders Need to Know Now

Topics of Discussion:

Star Ratings Update
Part D Redesign for 2027 and Beyond
Outreach and Appointments Rule Updates
TPMO Disclaimer Modification
Advertising Restrictions Relaxed
Supplemental Benefit Rules Finalized
SSBCI Clarification
Deregulatory Changes
D-SNP Change Finalized
Not Every Proposed Change Was Finalized
What Medicare Agents Should Do Now
What Agency Leaders and Sales Managers Should Do Now

⌛Short on time?

Listen to the post from Archer, our AI teaching assistant!

Archer is completely scripted by a human team member and utilizes an AI voice transcription to read the article and provide greater context!

We hope you enjoy and leave a comment!

CMS has officially released the Contract Year 2027 Medicare Advantage and Part D Final Rule, and there are several important updates agents, agency leaders, and sales managers should start paying attention to now. CMS issued the final rule on April 2, 2026. The rule is effective June 1, 2026, applies to coverage beginning January 1, 2027, and CMS notes that the new marketing and communications policies apply beginning October 1, 2026 for CY 2027 marketing.

This final rule does a few things at once:

It finalizes several operational and marketing changes that will affect how plans and agents interact with beneficiaries.
It codifies the Part D redesign changes tied to the Inflation Reduction Act.
It reshapes parts of the Star Ratings program.
And notably, it does not finalize every proposal CMS originally put on the table.

So let’s break this down.

The Big Picture

If I had to summarize the 2027 Final Rule in one sentence:

CMS is trying to simplify certain operational requirements, reduce some regulatory burden, and refocus quality oversight on areas it believes matter more to outcomes and beneficiary experience.

CMS says the final rule is intended to improve quality and access, simplify plan comparison, strengthen Part D financial protections, and streamline enrollment-related processes.

For agents and agencies, that means this rule is not just “policy news.”

It affects:

how carriers may position themselves in 2027,
how marketing and enrollment conversations may be handled,
how compliance teams will interpret new boundaries,
and how agents should prepare for AEP 2027.

1) Star Ratings Are Being Simplified — and That Matters

One of the biggest finalized changes is to the Star Ratings methodology.

CMS finalized two major moves:

First, CMS is not implementing the Excellent Health Outcomes for All reward, which was previously called the Health Equity Index reward, for the 2027 Star Ratings. Instead, CMS will continue using the historical reward factor.
Second, CMS is streamlining the measure set by removing 11 measures focused on administrative processes and areas with little meaningful variation between plans. CMS is also adding a new Part C Depression Screening and Follow-Up measure, beginning with the 2027 measurement year for the 2029 Star Ratings.

Why this matters for agents and agency leaders

Star Ratings are not just a carrier issue. They affect quality bonus payments, rebates, benefits, and market positioning. If carriers gain or lose quality advantage, that can eventually show up in plan competitiveness, supplemental benefit strategy, and how attractive certain products are in the field.

My read on this is simple:

CMS appears to be shifting away from a broader administrative-heavy quality structure and trying to refocus ratings on clinical care, outcomes, and patient experience. That may sound abstract, but it has downstream effects for agencies because strong member experience, lower complaints, cleaner enrollments, and better plan fit all become even more important over time.

2) CMS Codified the Part D Redesign for 2027 and Beyond

CMS also finalized the codification of major Part D redesign changes tied to the Inflation Reduction Act of 2022, because the temporary program instruction authority CMS had been using expires.

CMS says the final rule codifies, among other things:

elimination of the coverage gap phase,
a reduced annual out-of-pocket threshold,
no enrollee cost sharing in the catastrophic phase,
and the Manufacturer Discount Program that replaced the Coverage Gap Discount Program on January 1, 2025. CMS also codified operational changes involving True Out-Of-Pocket costs, specialty-tier rules, reinsurance payment methodologies, and the Selected Drug Subsidy.

Why this matters

This is important for agents because even if these changes are not brand new conceptually, they are now more firmly embedded in the regulatory framework for 2027 and beyond. That means agents need to stay sharp on how Part D cost structure, catastrophic coverage, and out-of-pocket protections actually work when discussing PDP and MAPD options with beneficiaries.

For agencies, this is another reminder that drug coverage education can’t be treated as secondary. If agents do not understand how the redesigned Part D structure affects plan comparisons, beneficiary costs, and medication conversations, mistakes happen.

3) CMS Relaxed Several “Time and Manner” Rules for Outreach and Appointments

This is one of the most agent-relevant parts of the final rule.

CMS finalized all of the main provisions under what it called Removing Rules on Time and Manner of Beneficiary Outreach. That includes:

allowing a marketing event to directly follow an educational event in the same location, as long as beneficiaries are appropriately notified and given an opportunity to leave,
eliminating the 48-hour waiting period between completing a Scope of Appointment and having a personal marketing appointment,
and allowing SOA forms to be made available and received at educational events.

Why this matters

This is a meaningful operational change.

For agents, it can make the sales process more practical and less clunky. For agencies, it can reduce friction in event-based workflows, appointment setting, and same-day follow-up. But this does not mean compliance disappears. It means the old timing restrictions are loosened, while the responsibility to maintain a compliant, non-pressured beneficiary experience remains.

My opinion here: some of the prior rules created administrative friction without always improving the consumer experience. CMS seems to be acknowledging that and moving back toward flexibility. But flexibility only helps agencies that already have good training and supervision in place.

4) The TPMO Disclaimer Was Modified — Not Eliminated

CMS also finalized changes to the TPMO disclaimer.

The final rule changes the timing so the disclaimer no longer has to be read within the first minute of the call. Instead, it must be conveyed prior to the discussion of any benefits. CMS also finalized removing SHIPs from the disclaimer language and continuing to direct beneficiaries to Medicare.gov or 1-800-MEDICARE for plan information. CMS did not eliminate the TPMO disclaimer entirely.

Why this matters

This is important because it gives agents and TPMOs more natural call flow flexibility, especially in conversations where basic demographic screening or election period validation comes first. But again, this is not a free-for-all. The disclaimer still exists, and it still must come before benefits are discussed.

So the takeaway is:

The timing changed. The obligation did not.
That means training teams and compliance leaders should revisit scripting, QA scorecards, and call-flow coaching before October 1, 2026.

5) CMS Relaxed Some Advertising Restrictions — But Support Still Matters

CMS also finalized provisions relaxing certain restrictions on language in advertising. In practical terms, CMS finalized the proposal so that a quantifiable superlative can still be used if it is factually supportable, but the supporting documentation no longer has to appear directly in the material itself. CMS also noted that plans remain ultimately responsible for oversight of entities marketing on their behalf.

Why this matters

This may reduce some administrative burden for plans and marketers, especially when producing materials quickly, but it does not remove the need for evidence. If a marketing claim is challenged, the plan still needs to be able to support it.

For agencies and field marketing organizations, this means marketing review processes still matter. Just because documentation does not have to sit directly in the piece does not mean unsupported claims are suddenly safe.

6) Supplemental Benefit Rules Were Finalized — but CMS Pulled Back on One Big Marketing Proposal

CMS finalized some important supplemental benefit-related provisions.

CMS finalized a requirement that MA plans disclose all supplemental benefits, including applicable conditions and limitations, eligible OTC items, and benefits accessible through debit cards. CMS also finalized debit-card administration requirements, including a reimbursement pathway when the debit card is unusable. At the same time, CMS did not finalize the proposal that would have prohibited MA organizations from marketing the dollar value of a supplemental benefit or the method by which it is administered, such as through a debit card.

CMS also finalized a separate supplemental benefit transparency change requiring plans to publicly post their plan-developed SSBCI eligibility criteria, and it finalized clarification that debit cards must be electronically linked to covered items and services through a real-time identification mechanism and limited to the specific plan year.

Why this matters

This is a mixed result.

CMS did not go as far as originally proposed on restricting how supplemental benefit dollar amounts can be marketed, which many in the industry will likely see as a meaningful outcome. But CMS did still move forward on stronger disclosure and administrative guardrails.

My takeaway:

Agencies should not interpret this as permission to get sloppy with flex card or OTC messaging. If anything, it reinforces the need for clearer explanations, not more hype.

7) CMS Clarified What Is and Is Not Allowable as SSBCI

CMS finalized a clarification that cannabis products illegal under applicable state or federal law are not allowable as Special Supplemental Benefits for the Chronically Ill. At the same time, the rule clarifies that certain hemp-seed-derived ingredients, such as hulled hemp seed, hemp seed protein powder, and hemp seed oil, may be allowable consistent with FDA treatment of those ingredients.

Why this matters

For most agents, this will not be an everyday sales issue. But for carriers, product teams, and anyone discussing supplemental benefit design, it matters because CMS is trying to tighten the line between what is compliant supplemental benefit design and what is not.

8) CMS Also Finalized Several Deregulatory Changes

(Updated: 4/7/2026)

CMS finalized several burden-reduction changes, including:

exempting certain account-based plans from creditable coverage disclosure requirements,
rescinding the mid-year notice about unused supplemental benefits,
eliminating the requirement that MA quality improvement programs include activities to reduce health disparities,
removing certain health equity requirements for MA Utilization Management Committees,
waiving the requirement for the LI NET program to maintain toll-free call center hours from 8 a.m. to 8 p.m. in all regions,
removing restrictions on the time and manner by which beneficiaries can have conversations with licensed agents and brokers,
and revising the retention rules for marketing and sales call recordings, reducing the overall retention timeframe from 10 years to 6 years, with years 1 through 3 retained as audio recordings and years 4 through 6 permitted as either audio recordings or transcripts.Enrollment records tied to telephonic enrollments remain subject to separate 10-year retention requirements.

Why this matters

Some of these are more operational than agent-facing, but they still matter because they shape how carriers, agencies, and downstream entities build compliance processes, documentation standards, oversight workflows, and beneficiary communications.

The call-recording change is a good example: it reduces long-term storage burden, but it does not eliminate oversight expectations. Organizations still need to preserve audio for the first three years, maintain acceptable records through year six, and continue treating telephonic enrollment recordings as enrollment documentation where applicable. In general, this portion of the rule reflects CMS’s stated goal of removing duplicative or burdensome requirements while keeping core beneficiary protections in place.

9) A Technical but Important D-SNP Change Was Finalized

CMS also finalized a D-SNP-related modification for states that do not mandate Medicaid managed care for all full-benefit duals. The final rule allows, under certain state-contract conditions, coordination-only D-SNPs and HIDE SNPs to continue enrolling full-benefit dually eligible individuals who are enrolled in Medicaid fee-for-service, and CMS modified the proposal by removing the originally proposed “majority” threshold for HIDE SNPs.

Why this matters

This is more technical and state-specific, but it matters for organizations working heavily in D-SNP markets because it affects enrollment alignment strategy and avoids some unintended barriers in states without mandatory Medicaid managed care.

10) Not Every Proposed Change Made It Into the Final Rule

This is important.

Two proposals that drew a lot of attention did not make it through in final form:

CMS says it is not finalizing the proposal to create a special enrollment period for provider terminations. CMS says it will continue to consider this topic in future rulemaking. CMS also did not finalize the proposal to prohibit MA organizations from marketing the dollar value of supplemental benefits or the method by which those benefits are administered.

Why this matters

This is a reminder that the final rule is not just a copy-and-paste version of the proposed rule. Some ideas moved forward. Some were softened. Some were dropped.

For agents, that means you cannot assume that every headline from the proposed rule phase survived into the final version.

What Medicare Agents Should Do Now

If you are a Medicare insurance agent, here is the practical takeaway:

First, review how these changes affect your sales flow, especially around SOAs, educational events, and when disclaimers must be given.
Second, make sure you understand the Part D redesign well enough to explain it clearly to beneficiaries.
Third, expect carriers and agencies to revisit marketing materials, scripts, QA forms, and event practices well ahead of October 1, 2026.

And fourth, do not confuse “less restrictive” with “less compliant.” In some areas this rule removes friction, but the expectation for clean business, clear documentation, and compliant communication is still very much there.

What Agency Leaders and Sales Managers Should Do Now

If you lead agents, I would focus on four things now:

1. Update training content early

Do not wait until AEP season to reteach event rules, SOA timing, or disclaimer changes. These marketing-related changes begin October 1, 2026.

2. Revisit compliance monitoring

QA scorecards, call reviews, and field event oversight should all be reviewed against the finalized rule language.

3. Prepare for carrier variation

Even when CMS loosens a rule, carriers may still layer on their own expectations. Agency leaders should expect some carriers to move faster than others on implementation. This is an inference based on how carriers typically operationalize CMS changes. We may see these changes when the new AHIP and carrier trainings are released.

4. Use this as a training opportunity

This rule is another example of why Medicare training cannot be limited to AHIP and carrier certs. Agents need structured support to understand what changed, what did not, and how to apply it in real conversations. That is an inference drawn from the operational changes finalized here.

Final Thoughts

The 2027 Final Rule is not a minor update.

It reshapes several areas that matter directly to agents and agencies: Star Ratings, Part D structure, outreach rules, SOAs, disclaimers, supplemental benefits, and administrative burden. It also confirms something we continue to see across the industry:

The agencies that do best are the ones that adapt early, train clearly, and operationalize policy changes before they become last-minute compliance problems.

This rule gives the industry more flexibility in some places.

What agencies do with that flexibility will matter.